LGVN FY 2023 Earnings — Longeveron Inc. Revenue & Financial Results | Market Cap Arena

LGVNLongeveron Inc.

$20M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$709,000-42.0% YoY

Gross Profit

$221,00031.2% margin

Operating Income

-$21M-2966.0% margin

Net Income

-$21M-3020.2% margin

EPS (Diluted)

$-10.22

Cash Flow

Operating Cash Flow

-$19M

Free Cash Flow

-$19M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$12M

Total Liabilities

$5M

Stockholders' Equity

$7M

Cash & Equivalents

$5M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$709,000	$1M	-42.0%
Gross Profit	$221,000	$497,000	-55.5%
Operating Income	-$21M	-$18M	-16.5%
Net Income	-$21M	-$19M	-13.7%